Prevention of adjuvant-induced cachexia in rats by cyclosporin A
- PMID: 2318512
- DOI: 10.1038/icb.1990.9
Prevention of adjuvant-induced cachexia in rats by cyclosporin A
Abstract
The changes in food intake and biochemistry following Freund's adjuvant (AJ)-induced inflammation in rats were investigated. Injection of AJ into rats resulted in a transient anorexia but a sustained decrease in body weight. Within 14 days, body weight decreased by 12% (P less than 0.05) and adipose tissue (retroperitoneal fat pads) decreased by more than 50%. Biochemical changes seen in association with the AJ-induced wasting included decreased plasma concentrations of triglyceride and cholesterol. Injection of cyclosporin-A (CS) (20 mg/kg) with the AJ decreased the anorexia, prevented the sustained loss of body weight and adipose tissue and reversed the effects on plasma triglyceride and cholesterol concentrations. Insulin concentrations were not significantly affected by the AJ or AJ/CS treatments. Peritoneal macrophages from AJ-treated rats produced 3-fold more tumour necrosis factor-alpha (cachectin) than control rats. This effect was not observed in rats treated with AJ plus CS. The results are consistent with CS preventing the release of cytokines which have anorectic and catabolic actions (IL-1, TNF), although there is also the possibility that CS has effects involving endocrine mechanisms.
Similar articles
-
Changes in plasma zinc, copper, iron, and hepatic metallothionein in adjuvant-induced arthritis treated with cyclosporin.Biol Trace Elem Res. 1992 Sep;34(3):237-48. doi: 10.1007/BF02783679. Biol Trace Elem Res. 1992. PMID: 1384614
-
Subcutaneous cyclosporin prevents the development of complete Freund's adjuvant-streptozotocin-induced diabetes in the rat.Diabete Metab. 1991 Mar-Apr;17(2):281-5. Diabete Metab. 1991. PMID: 1830858
-
Effects of aging and cytokine blockade on inflammatory cachexia.Clin Exp Rheumatol. 2004 Jan-Feb;22(1):85-90. Clin Exp Rheumatol. 2004. PMID: 15005009
-
Anti-inflammatory effect of the ghrelin agonist growth hormone-releasing peptide-2 (GHRP-2) in arthritic rats.Am J Physiol Endocrinol Metab. 2005 Mar;288(3):E486-92. doi: 10.1152/ajpendo.00196.2004. Epub 2004 Oct 26. Am J Physiol Endocrinol Metab. 2005. PMID: 15507538
-
TNF-α and cancer cachexia: Molecular insights and clinical implications.Life Sci. 2017 Feb 1;170:56-63. doi: 10.1016/j.lfs.2016.11.033. Epub 2016 Dec 3. Life Sci. 2017. PMID: 27919820 Review.
Cited by
-
Professor Barrie Vernon-Roberts, AO, MD, BSc, PhD, FRCPath, FRCPA, FAOrthA (Hon), FRS.SA.Inflammopharmacology. 2013 Aug;21(4):269-77. doi: 10.1007/s10787-013-0176-6. Epub 2013 Jul 4. Inflammopharmacology. 2013. PMID: 23824627
-
Changes in plasma zinc, copper, iron, and hepatic metallothionein in adjuvant-induced arthritis treated with cyclosporin.Biol Trace Elem Res. 1992 Sep;34(3):237-48. doi: 10.1007/BF02783679. Biol Trace Elem Res. 1992. PMID: 1384614
-
Wasting in adjuvant-induced arthritis and its relationship to plasma zinc, copper and liver metallothionein.Agents Actions. 1994 Aug;42(1-2):60-2. doi: 10.1007/BF02014302. Agents Actions. 1994. PMID: 7847186
-
Sustained pain-related depression of behavior: effects of intraplantar formalin and complete freund's adjuvant on intracranial self-stimulation (ICSS) and endogenous kappa opioid biomarkers in rats.Mol Pain. 2014 Sep 23;10:62. doi: 10.1186/1744-8069-10-62. Mol Pain. 2014. PMID: 25245060 Free PMC article.
-
Emu oil(s): a source of non-toxic transdermal anti-inflammatory agents in aboriginal medicine.Inflammopharmacology. 1998;6(1):1-8. doi: 10.1007/s10787-998-0001-9. Inflammopharmacology. 1998. PMID: 17638122
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources